x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 1, 2016 5:26 EST

HEMOLIFE MEDICAL, INC,: IMPACT SYSTEM is a disposable device for the treatment of systemic inflammation. It operates on standard filtration machines already available in hospitals and medical centers

iCrowdNewswire - Aug 1, 2016

HEMOLIFE MEDICAL, INC. Logo

HEMOLIFE MEDICAL, INC

DANA POINT, CA 92629, US
Medical Devices & Equipment

IMPACT SYSTEM is a disposable device for the treatment of systemic inflammation. It operates on standard filtration machines already available in hospitals and medical centers.

Our current mission is to treat acutely ill patients with life threatening sepsis or liver coma. Our technology is intended to enhance current standard of care to increase patient survival.

Products / Services

IMPACT SYSTEM

Extracorporeal plasma separation/toxin adsorption system for treating diseases associated
with systemic inflammation. Current approval is for sale in Canada, EU, Singapore and India
for the treatment of liver coma and sepsis/severe sepsis/septic shock.

Utilizes currently available pump devices used for blood filtration.

 

Management

President
Lon Stone
 
 

Summary

Prior Year Revenue Current Year Revenue Next Year Revenue

 

Company Age Employees Sub-Industry
14 years, 6 months 6 Therapeutic

 

Company Type Stock Exchange Stock Symbol
Privately-Held

 

Contact Information:

Lon Stone [email protected]

View Related News >
support